CardiacSense

About:

CardiacSense is a developer of a wearable technology for continuous cardiac arrhythmia detection and non-inflating blood pressure monitoring

Website: https://www.cardiacsense.com

Top Investors: Israel Innovation Authority, EASME - EU Executive Agency for SMEs

Description:

CardiacSense is an innovative start-up on track to revolutionize the Wearable Health Industry by providing affordable, comfortable FDA & CE certified Medical Watches and Wristbands capable of continuous, long term, ambulatory and non-invasive monitoring of life critical functions including Heart Rate, Pulse Rate, Respiratory Rate, Core Temperature, Oxygen Saturation and Blood Pressure. These capabilities enable accurate real time diagnostics of medical conditions such as Heart Arrhythmias (incl. Atrial Fibrillation), Hypertension, COPD, Heart Failure, Sleep Apnea and infections (such as COVID-19).

Total Funding Amount:

$27M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Caesarea, Hefa, Israel

Founded Date:

2009-12-29

Contact Email:

info(AT)cardiacsense.com

Founders:

Eldad Shemesh

Number of Employees:

11-50

Last Funding Date:

2022-05-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai